Weight-Loss drug before heart procedure may boost success in AF patients
Disease control
Not yet recruiting
This study tests whether taking semaglutide (Wegovy) before a standard heart procedure called catheter ablation can help people with atrial fibrillation (an irregular heartbeat) stay free of heart rhythm problems for longer. The trial will enroll 200 adults who are overweight or …
Phase: PHASE4 • Sponsor: Emma Svennberg • Aim: Disease control
Last updated May 08, 2026 03:09 UTC